title: Significant publications on infectious diseases pharmacotherapy in 2012.
abstract: OBJECTIVE
  The most important articles pertaining to infectious diseases (ID) pharmacotherapy published in 2012, as nominated and ranked by panels of pharmacists and physicians with ID expertise, are summarized.
  
  
  CONCLUSIONS
  Members of the Houston Infectious Diseases Network were asked to nominate articles on ID research published in prominent peer-reviewed journals during the period January 1-December 31, 2012, with a major impact in the field of ID pharmacotherapy. A list of 42 nominated articles on general ID-related topics and 8 articles pertaining to human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS) was compiled. In a survey conducted in January 2013, members of the Society of Infectious Diseases Pharmacists (SIDP) were asked to select from the list 10 general ID articles and 1 HIV/AIDS-related article that they considered to be the most important. Of the 180 SIDP members surveyed, 100 (55%) and 44 (24%) participated in ranking the general ID and HIV/AIDS-related articles, respectively. Summaries of the highest-ranked articles in both categories are presented here.
  
  
  CONCLUSIONS
  With the volume of published ID-related research growing each year, both ID specialists and nonspecialists are challenged to stay current with the literature. Key ID-related publications in 2012 included updated recommendations on management of diabetic foot infections, articles on promising approaches to prevention and early treatment of HIV disease, and reports on developments in research on pharmacotherapies for methicillin-resistant Staphylococcus aureus bacteremia and Klebsiella pneumoniae infections.
authors.affiliation: Dana R. Bowers, Pharm.D., BCPS, is Infectious Diseases Pharmacotherapy Fellow, Department of Clinical Sciences and Administration, College of Pharmacy, University of Houston, Houston, TX. Andrew S. Hunter, Pharm.D., BCPS, is Clinical Specialist-Infectious Diseases, Michael E. DeBakey Veterans Affairs Medical Center, Houston. David M. Jacobs, Pharm.D., BCPS, is Postgraduate Year 2 Infectious Diseases Resident, Cardinal Health, Houston, and Department of Clinical Sciences and Administration, College of Pharmacy, University of Houston. Kristi M. Kuper, Pharm.D., BCPS, GSPC, is Clinical Pharmacy Manager, VHA Performance Services, Houston. William L. Musick, Pharm.D., BCPS, is Clinical Specialist-Infectious Diseases; and Katherine K. Perez, Pharm.D., BCPS, is Clinical Specialist-Infectious Diseases, The Methodist Hospital, Houston. Dhara N. Shah, Pharm.D., BCPS, is Research Assistant Professor, Department of Clinical Sciences and Administration, College of Pharmacy, University of Houston. Amy N. Schilling, Pharm.D., BCPS, is Clinical Practice Specialist-Internal Medicine/Infectious Diseases, University of Texas Medical Branch, Galveston.
authors.forename: Dana R
authors.initials: DR
authors.lastname: Bowers
authors.forename: Andrew S
authors.initials: AS
authors.lastname: Hunter
authors.forename: David M
authors.initials: DM
authors.lastname: Jacobs
authors.forename: Kristi M
authors.initials: KM
authors.lastname: Kuper
authors.forename: William L
authors.initials: WL
authors.lastname: Musick
authors.forename: Katherine K
authors.initials: KK
authors.lastname: Perez
authors.forename: Dhara N
authors.initials: DN
authors.lastname: Shah
authors.forename: Amy N
authors.initials: AN
authors.lastname: Schilling